Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin US Large Cap Multifactor Index ETF
FLQL
|
+$514M |
| 2 |
Target
TGT
|
+$487M |
| 3 |
Wells Fargo
WFC
|
+$384M |
| 4 |
Apple
AAPL
|
+$257M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$597M |
| 2 |
Restaurant Brands International
QSR
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$318M |
| 4 |
JPMorgan Chase
JPM
|
+$310M |
| 5 |
Analog Devices
ADI
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.33% |
| 2 | Technology | 15.62% |
| 3 | Financials | 14.4% |
| 4 | Industrials | 9.04% |
| 5 | Communication Services | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
676
DELISTED
bluebird bio
BLUE
| $23.4M | 0.01% |
11,480
| – | – |
|
677
Huntington Bancshares
HBAN
$35.1B
| $23.3M | 0.01% |
1,839,932
-11,682
| -0.6% | -$157K |
|
678
HCA Healthcare
HCA
$84.8B
| $23.3M | 0.01% |
178,805
+126,512
| +242% | +$17M |
|
679
Boston Properties
BXP
$11B
| $23M | 0.01% |
171,601
+13,970
| +9% | +$1.79M |
|
680
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $23M | 0.01% |
186,429
+178,198
| +2,165% | +$21.7M |
|
681
Valero Energy
VLO
$89.8B
| $22.7M | 0.01% |
267,840
+91,848
| +52% | +$7.59M |
|
682
Allogene Therapeutics
ALLO
$601M
| $22.6M | 0.01% |
788,979
+289,797
| +58% | +$8.41M |
|
683
BBVA Argentina
BBAR
$3.85B
| $22.5M | 0.01% |
2,370,859
+925,100
| +64% | +$11M |
|
684
Alexandria Real Estate Equities
ARE
$8.88B
| $22.5M | 0.01% |
157,860
-6,592
| -4% | -$868K |
|
685
Amdocs
DOX
$5.53B
| $22.4M | 0.01% |
414,589
+19,694
| +5% | +$1.11M |
|
686
Brookfield Renewable
BEP
$10B
| $22.3M | 0.01% |
1,312,856
-89,552
| -6% | -$1.41M |
|
687
Cinemark Holdings
CNK
$3.82B
| $22.1M | 0.01% |
552,848
+544,222
| +6,309% | +$21.3M |
|
688
Las Vegas Sands
LVS
$30.5B
| $22M | 0.01% |
360,807
+30,264
| +9% | +$1.78M |
|
|
TRST
689
Trustco Bank Corp NY
TRST
$977M
| $22M | 0.01% |
566,707
+57,488
| +11% | +$2.28M |
|
|
CBIO
690
Crescent Biopharma
CBIO
$602M
| $21.9M | 0.01% |
17,607
-2,073
| -11% | -$2.37M |
|
691
Brookfield Infrastructure Partners
BIP
$18.8B
| $21.9M | 0.01% |
880,632
+13,777
| +2% | +$324K |
|
|
NVO
692
Novo Nordisk
NVO
$216B
| $21.7M | 0.01% |
828,910
-93,426
| -10% | -$2.3M |
|
693
IAMGOLD
IAG
$8.47B
| $21.7M | 0.01% |
6,246,432
-20,568
| -0.3% | -$72K |
|
694
Camden Property Trust
CPT
$11.3B
| $21.6M | 0.01% |
212,549
+16,104
| +8% | +$1.55M |
|
695
Precision BioSciences
DTIL
$188M
| $21.5M | 0.01% |
+40,004
| New | +$21.2M |
|
|
AIMC
696
DELISTED
Altra Industrial Motion Corp
AIMC
| $21.2M | 0.01% |
682,857
-31,281
| -4% | -$948K |
|
697
TriMas Corp
TRS
$1.43B
| $21M | 0.01% |
694,418
| – | – |
|
698
Atlantic Union Bankshares
AUB
$5.99B
| $20.9M | 0.01% |
+647,554
| New | +$21.6M |
|
699
Eldorado Gold
EGO
$8.31B
| $20.7M | 0.01% |
4,490,075
+414,911
| +10% | +$1.62M |
|
700
ConocoPhillips
COP
$147B
| $20.7M | 0.01% |
310,193
+29,662
| +11% | +$2M |
|
Similar funds
Franklin Resources's Q1 2019 Portfolio in Review
As of Q1 2019, Franklin Resources held 1,583 positions worth $187B, up 13% from $166B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Franklin Resources's Q1 2019 filing shows 113 new, 618 increased, 562 reduced and 100 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,189,251 shares worth $200M. The largest sale was Eli Lilly, an estimated $597M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- Franklin Resources's largest Q1 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,189,251 shares worth $200M.
- Franklin Resources added most to Franklin US Large Cap Multifactor Index ETF in Q1 2019, an estimated $514M increase.
- Franklin Resources's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $597M.
- Franklin Resources fully exited FCB Financial Holdings, Inc. in Q1 2019, selling an estimated $79.2M.
- Franklin Resources's ten largest holdings make up 12% of its $187B portfolio in Q1 2019.
- Franklin Resources opened 113 new positions and closed 100 in Q1 2019.
- Franklin Resources's portfolio value rose 13% quarter-over-quarter to $187B.
Based on Franklin Resources's 13F filing for Q1 2019, filed 14 May 2019.